Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Enterprise Value (2019 - 2025)

Pulmonx (LUNG) has disclosed Enterprise Value for 7 consecutive years, with -$8.8 million as the latest value for Q2 2025.

  • Quarterly Enterprise Value rose 92.35% to -$8.8 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$88.7 million through Mar 2025, up 23.62% year-over-year, with the annual reading at -$101.5 million for FY2024, 13.34% up from the prior year.
  • Enterprise Value for Q2 2025 was -$8.8 million at Pulmonx, up from -$88.7 million in the prior quarter.
  • The five-year high for Enterprise Value was -$8.8 million in Q2 2025, with the low at -$219.1 million in Q1 2021.
  • Average Enterprise Value over 5 years is -$138.8 million, with a median of -$138.1 million recorded in 2022.
  • The sharpest move saw Enterprise Value crashed 1248.85% in 2021, then skyrocketed 92.35% in 2025.
  • Over 5 years, Enterprise Value stood at -$180.0 million in 2021, then rose by 21.61% to -$141.1 million in 2022, then rose by 17.03% to -$117.1 million in 2023, then rose by 13.34% to -$101.5 million in 2024, then soared by 91.37% to -$8.8 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$8.8 million, -$88.7 million, and -$101.5 million for Q2 2025, Q1 2025, and Q4 2024 respectively.